A Vaxcyte Executive Just Cashed Options Struck at $5.35. Here's What Long-Term Investors Should Know
Key PointsThe transactions represented a combined value of about $378,000 based on weighted average prices of $61.12 per share.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.